Acquiring Company
Pfizer
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticalsDescription
Pfizer has announced the acquisition of Seagen for $43 billion, marking a significant expansion in its oncology portfolio. This strategic move is part of Pfizer's ongoing efforts to enhance its product offerings and revenue streams in the competitive biotech industry. The acquisition aligns with Pfizer's commitment to delivering innovative cancer therapies and improving patient outcomes.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Pfizer to acquire Metsera for $10 billion, $10B (November 15, 2025)
- Pfizer increases bid for Metsera in bidding war (November 8, 2025)
- Pfizer secures clearance for Metsera acquisition (October 31, 2025)
- Pfizer acquires Metsera for $7.3 billion, $7.3B (October 13, 2025)
- Pfizer to acquire Metsera for $7.3 billion, $7.3B (September 22, 2025)
- AbbVie completes acquisition of Capstan Therapeutics (August 19, 2025)
Who to call at Pfizer, and when
When Pfizer changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pfizer, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pfizer makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.